QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Olaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort. 会议论文 Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019 作者:  Wu, Lingying;  Zhu, Jianqing;  Yin, Rutie;  Wu, Xiaohua;  Lou, Ge 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/31 Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20 作者:  Scambia, Giovanni;  Johnson, Toby;  Floquet, Anne;  Heitz, Florian;  Park, Sang-Yoon 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma 会议论文 作者:  Zang, Rongyu;  Wu, Lingying;  Zhu, Jianqing;  Kong, Beihua;  Kim, Byoung-Gie 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20 作者:  Zang, Rongyu;  Wu, Lingying;  Zhu, Jianqing;  Kong, Beihua;  Kim, Byoung-Gie 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma 会议论文 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2013 作者:  Zang, Rongyu;  Wu, Lingying;  Zhu, Jianqing;  Kong, Beihua;  Kim, Byoung-Gie 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/31